Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Frontiers in Bioscience : a Journal and Virtual Library|March 17, 2005
Culture conditions influence uptake and intracellular localization of the membrane permeable cGMP-dependent protein kinase inhibitor DT-2Kevin F Foley, Sergio De Frutos, Kristina E Laskovski, et al.Ground Water|May 10, 2006
Interpreting velocities from heat-based flow sensors by numerical simulationGrace W Su, Barry M Freifeld, Curtis M Oldenburg, et al.Psychopharmacology|August 31, 2015
Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male ratsCharles W Schindler, Eric B Thorndike, Steven R Goldberg, et al.Biochemistry|April 16, 2014
Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamineUyen B Chu, Sevahn K Vorperian, Kenneth Satyshur, et al.Molecular Informatics|November 19, 2016
Combined Simulation and Mutation Studies to Elucidate Selectivity of Unsubstituted Amphetamine-like Cathinones at the Dopamine TransporterAmir Seddik, Daan P Geerke, Thomas Stockner, et al.Journal of the Neurological Sciences|April 6, 2024
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.ACS Omega|July 21, 2020
Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinRobert B Kargbo, Alexander Sherwood, Andrew Walker, et al.Journal of Chemical Neuroanatomy|February 7, 2017
Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporterAparna Shekar, Jenny I Aguilar, Greta Galli, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 13, 2020
Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.Journal of Psychopharmacology (Oxford, England)|June 28, 2018
High dose psilocybin is associated with positive subjective effects in healthy volunteersChristopher R Nicholas, Kelsey M Henriquez, Michele C Gassman, et al.Pageof 5